Physician profile
Anthony Viol
NPI 1770757510
$2,790.64
in general payments reported to CMS, 2019-2025
35 companies · $353 in 2025
The $353 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $253 · 2020: $343 · 2021: $321 · 2022: $551 · 2023: $513 · 2024: $457 · 2025: $353.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,323.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,323.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $685.46 | 2021-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Surgiclose |
| Smith+Nephew, INC. | $510.97 | 2019-2025 | Pico, Stravix, Grafix |
| Medela LLC | $181.76 | 2021-2022 | |
| Misonix INC | $134.82 | 2019-2020 | |
| Organogenesis INC. | $133.06 | 2019-2025 | Puraply Wound Matrix, Puraply |
| Integra Lifesciences Corporation | $116.34 | 2020-2022 | |
| Allergan, INC. | $96.66 | 2019-2022 | |
| Polynovo North America LLC | $89.89 | 2022-2025 | Novosorb Btm |
| Lifenet Health | $78.65 | 2023-2025 | Theragenesis Wound Matrix |
| Kci USA, INC. | $74.44 | 2019-2020 | |
| Convatec INC. | $68.75 | 2021-2023 | |
| Abbvie INC. | $53.31 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $44.99 | 2023-2024 | Glassia |
| Tactile Systems Technology INC | $42.90 | 2019-2023 | Entre Plus, Flexitouch Plus |
| Avita Medical Americas, LLC | $39.54 | 2023 | Recell |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tela Bio, INC. | $36.97 | 2024-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Musculoskeletal Transplant Foundation INC. | $34.42 | 2019 | |
| Cashflow Solutions, LLC | $33.56 | 2023-2025 | Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White, Pcd-51 731a (US) - White |
| Solventum Corporation | $32.96 | 2024 | V.A.C. Veraflo, Prevena, Promogran Prisma |
| Urgo Medical North America, LLC | $32.74 | 2023-2024 | Urgok2, Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Urgoclean Ag |
| Reapplix INC. | $32.40 | 2024 | 3c Patch Kit - Box |
| Ets Wound Care LLC | $28.36 | 2024 | Mirragen Advanced Wound Matrix |
| Reprise Biomedical, INC. | $27.38 | 2025 | Miro3d |
| Medtronic, INC. | $20.26 | 2024 | Progrip |
| Paratek Pharmaceuticals, INC. | $16.57 | 2021 | |
| Ovik Health, LLC | $15.92 | 2021 | |
| Novo Nordisk INC | $15.80 | 2023 | Wegovy |
| Merck Sharp & Dohme LLC | $15.66 | 2020 | |
| Teleflex LLC | $15.40 | 2024 | Titan Sgs |
| Hartmann USA, INC. | $14.66 | 2023 | Zetuvit Plus |
| Bioventus LLC | $13.90 | 2022 | |
| Amarin Pharma, INC. | $13.87 | 2020 | |
| Sanara Medtech INC. | $13.71 | 2025 | Celleraterx |
| Stryker Corporation | $12.66 | 2019 | |
| Medtronic Vascular, INC. | $11.90 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Viol listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.